We are live on ! Find out more
HC

Henshaw Capital Portfolio holdings

AUM $3.07B
1-Year Est. Return 40.85%
This Fund
S&P 500
This Quarter Est. Return
-13.93%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$1.44B
AUM Growth
-$266M
Cap. Flow
-$4.59M
Cap. Flow %
-0.32%
Top 10 Hldgs %
33.34%
Holding
325
New
10
Increased
75
Reduced
47
Closed
24

Top Buys

Rank Stock Value
1
BURL icon
Burlington
BURL
+$598K
2
TFX icon
Teleflex
TFX
+$547K
3
GDDY icon
GoDaddy
GDDY
+$471K
4
BMY icon
Bristol-Myers Squibb
BMY
+$452K
5
XMTR icon
Xometry
XMTR
+$416K

Top Sells

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$999K
2
C icon
Citigroup
C
+$675K
3
WRB icon
W.R. Berkley
WRB
+$655K
4
CSL icon
Carlisle Companies
CSL
+$506K
5
WSC icon
WillScot Mobile Mini Holdings
WSC
+$502K

Sector Composition

Rank Sector Weight
1 Technology 24.14%
2 Industrials 16.41%
3 Healthcare 12.77%
4 Financials 11.85%
5 Communication Services 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PB icon
101
Prosperity Bancshares
PB
$8.69B
$1.06M 0.07%
15,506
– –
GGG icon
102
Graco
GGG
$12.8B
$1.05M 0.07%
17,738
+59
+0.3% +$3.71K
POOL icon
103
Pool Corp
POOL
$6.83B
$1.04M 0.07%
2,954
+269
+10% +$107K
MANH icon
104
Manhattan Associates
MANH
$13B
$1M 0.07%
8,764
– –
NOC icon
105
Northrop Grumman
NOC
$77.5B
$981K 0.07%
2,049
+7
+0.3% +$3.21K
JNJ icon
106
Johnson & Johnson
JNJ
$646B
$960K 0.07%
5,410
-1,660
-23% -$296K
CI icon
107
Cigna
CI
$73.7B
$955K 0.07%
3,623
-465
-11% -$120K
DEO icon
108
Diageo
DEO
$51.7B
$917K 0.06%
5,269
-1,077
-17% -$205K
JKHY icon
109
Jack Henry & Associates
JKHY
$12.1B
$914K 0.06%
5,078
+14
+0.3% +$2.62K
BURL icon
110
Burlington
BURL
$17.1B
$905K 0.06%
6,643
+3,304
+99% +$598K
ACN icon
111
Accenture
ACN
$116B
$902K 0.06%
3,250
+9
+0.3% +$2.7K
TRMB icon
112
Trimble
TRMB
$14.2B
$857K 0.06%
14,713
+5,446
+59% +$358K
FDS icon
113
Factset
FDS
$11B
$841K 0.06%
2,186
+5
+0.2% +$1.96K
SONY icon
114
Sony
SONY
$145B
$807K 0.06%
49,350
-4,810
-9% -$85.2K
AZN icon
115
AstraZeneca
AZN
$252B
$799K 0.06%
6,050
-293
-5% -$38.4K
SO icon
116
Southern Company
SO
$102B
$780K 0.05%
10,940
– –
SHEL icon
117
Shell
SHEL
$250B
$777K 0.05%
14,855
– –
DUK icon
118
Duke Energy
DUK
$93.8B
$760K 0.05%
7,085
-1,072
-13% -$118K
TXN icon
119
Texas Instruments
TXN
$236B
$757K 0.05%
4,926
+32
+0.7% +$5.38K
COP icon
120
ConocoPhillips
COP
$157B
$737K 0.05%
8,203
-1,942
-19% -$200K
NVO
121
Novo Nordisk
NVO
$202B
$731K 0.05%
13,114
-210
-2% -$11.7K
DECK icon
122
Deckers Outdoor
DECK
$12B
$726K 0.05%
17,052
– –
MS icon
123
Morgan Stanley
MS
$337B
$702K 0.05%
9,224
– –
WWD icon
124
Woodward
WWD
$20.2B
$689K 0.05%
7,451
– –
HSIC icon
125
Henry Schein
HSIC
$9.98B
$664K 0.05%
8,652
– –
3 4
5
6 7

Similar funds

DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $3.07B AUM 16.75% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CI
Capital International Los Angeles, California $3.06B AUM 33.84% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $3.06B AUM 26.31% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Henshaw Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Henshaw Capital held 325 positions worth $1.44B, down 16% from $1.71B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Henshaw Capital's Q2 2022 filing shows 10 new, 75 increased, 47 reduced and 24 closed positions. Its largest new stake was Bristol-Myers Squibb: 5,930 shares worth $457K. The largest sale was Dentsply Sirona, an estimated $999K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Industrials and Healthcare.

  • Henshaw Capital's largest Q2 2022 buy was Bristol-Myers Squibb: 5,930 shares worth $457K.
  • Henshaw Capital added most to Burlington in Q2 2022, an estimated $598K increase.
  • Henshaw Capital's biggest Q2 2022 reduction was Citigroup, cutting an estimated $675K.
  • Henshaw Capital fully exited Dentsply Sirona in Q2 2022, selling an estimated $999K.
  • Henshaw Capital's ten largest holdings make up 33% of its $1.44B portfolio in Q2 2022.
  • Henshaw Capital opened 10 new positions and closed 24 in Q2 2022.
  • Henshaw Capital's portfolio value fell 16% quarter-over-quarter to $1.44B.

Based on Henshaw Capital's 13F filing for Q2 2022, filed 28 May 2026.